PAX Global Technology Limited

SEHK:327 Stock Report

Market Cap: HK$5.2b

PAX Global Technology Valuation

Is 327 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 327 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 327 (HK$4.86) is trading below our estimate of fair value (HK$5.24)

Significantly Below Fair Value: 327 is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 327?

Key metric: As 327 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 327. This is calculated by dividing 327's market cap by their current earnings.
What is 327's PE Ratio?
PE Ratio5.4x
EarningsHK$959.10m
Market CapHK$5.16b

Price to Earnings Ratio vs Peers

How does 327's PE Ratio compare to its peers?

The above table shows the PE ratio for 327 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average14.8x
1478 Q Technology (Group)
35.5x35.7%HK$6.7b
710 BOE Varitronix
9.5x20.8%HK$4.2b
3393 Wasion Holdings
10x22.8%HK$6.9b
2481 Wise Living Technology
4.3xn/aHK$844.5m
327 PAX Global Technology
5.4x14.3%HK$5.2b

Price-To-Earnings vs Peers: 327 is good value based on its Price-To-Earnings Ratio (5.4x) compared to the peer average (14.8x).


Price to Earnings Ratio vs Industry

How does 327's PE Ratio compare vs other companies in the HK Electronic Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
76 Elate Holdings
0.6xn/aUS$18.41m
1822 China Wood International Holding
0.07xn/aUS$10.88m
911 Qianhai Health Holdings
0.7xn/aUS$6.86m
No more companies available in this PE range
327 5.4xIndustry Avg. 8.7xNo. of Companies7PE0612182430+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 327 is good value based on its Price-To-Earnings Ratio (5.4x) compared to the Hong Kong Electronic industry average (8.7x).


Price to Earnings Ratio vs Fair Ratio

What is 327's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

327 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio5.4x
Fair PE Ratio10.7x

Price-To-Earnings vs Fair Ratio: 327 is good value based on its Price-To-Earnings Ratio (5.4x) compared to the estimated Fair Price-To-Earnings Ratio (10.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 327 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$4.86
HK$6.49
+33.4%
4.4%HK$6.77HK$6.20n/a2
Nov ’25HK$5.16
HK$6.49
+25.7%
4.4%HK$6.77HK$6.20n/a2
Oct ’25HK$5.20
HK$6.49
+24.7%
4.4%HK$6.77HK$6.20n/a2
Sep ’25HK$4.53
HK$6.49
+43.2%
4.4%HK$6.77HK$6.20n/a2
Aug ’25HK$4.30
HK$9.00
+109.2%
4.4%HK$9.39HK$8.60n/a2
Jul ’25HK$5.86
HK$9.00
+53.5%
4.4%HK$9.39HK$8.60n/a2
Jun ’25HK$6.23
HK$9.00
+44.4%
4.4%HK$9.39HK$8.60n/a2
May ’25HK$6.56
HK$9.00
+37.1%
4.4%HK$9.39HK$8.60n/a2
Apr ’25HK$6.17
HK$8.83
+43.1%
4.5%HK$9.39HK$8.50n/a3
Mar ’25HK$6.05
HK$8.83
+46.0%
4.5%HK$9.39HK$8.50n/a3
Feb ’25HK$5.47
HK$8.83
+61.4%
4.5%HK$9.39HK$8.50n/a3
Jan ’25HK$6.05
HK$8.83
+46.0%
4.5%HK$9.39HK$8.50n/a3
Dec ’24HK$5.70
HK$8.83
+54.9%
4.5%HK$9.39HK$8.50n/a3
Nov ’24HK$5.42
HK$8.83
+62.9%
4.5%HK$9.39HK$8.50HK$5.163
Oct ’24HK$5.53
HK$8.83
+59.7%
4.5%HK$9.39HK$8.50HK$5.203
Sep ’24HK$5.94
HK$8.83
+48.7%
4.5%HK$9.39HK$8.50HK$4.533
Aug ’24HK$6.46
HK$9.53
+47.5%
2.0%HK$9.80HK$9.39HK$4.303
Jul ’24HK$5.94
HK$9.53
+60.4%
2.0%HK$9.80HK$9.39HK$5.863
Jun ’24HK$6.10
HK$9.53
+56.2%
2.0%HK$9.80HK$9.39HK$6.233
May ’24HK$6.45
HK$9.53
+47.8%
2.0%HK$9.80HK$9.39HK$6.563
Apr ’24HK$6.59
HK$9.53
+44.6%
2.0%HK$9.80HK$9.39HK$6.173
Mar ’24HK$6.98
HK$12.46
+78.4%
18.9%HK$14.81HK$10.10HK$6.052
Feb ’24HK$7.55
HK$12.46
+65.0%
18.9%HK$14.81HK$10.10HK$5.472
Jan ’24HK$6.75
HK$12.46
+84.5%
18.9%HK$14.81HK$10.10HK$6.052
Dec ’23HK$6.84
HK$12.10
+76.9%
16.4%HK$14.81HK$10.10HK$5.703
Nov ’23HK$6.39
HK$12.10
+89.4%
16.4%HK$14.81HK$10.10HK$5.423

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies